Theraclion SA
PAR:ALTHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chengzhi Co Ltd
SZSE:000990
|
CN |
|
J
|
Jiangxi Synergy Pharmaceutical Co Ltd
SZSE:300636
|
CN |
|
Ortel Communications Ltd
NSE:ORTEL
|
IN |
Theraclion SA
Total Equity
Theraclion SA
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Theraclion SA
PAR:ALTHE
|
Total Equity
-€2.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Total Equity
€23.3m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
|
Biomerieux SA
PAR:BIM
|
Total Equity
€4.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Total Equity
€12.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Total Equity
€6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Total Equity
€94.7m
|
CAGR 3-Years
19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Theraclion SA
Glance View
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
See Also
What is Theraclion SA's Total Equity?
Total Equity
-2.5m
EUR
Based on the financial report for Jun 30, 2025, Theraclion SA's Total Equity amounts to -2.5m EUR.
What is Theraclion SA's Total Equity growth rate?
Total Equity CAGR 5Y
-5%
